Gerresheimer Medical Systems, together with US-based Portal Instruments, has manufactured a new primary drug container for use in needle-free automatic injection systems.
The cartridge-like container, made of the high-performance polymer COP, serves as the primary packaging for the sensitive active agent and is equipped with a nozzle, with which the hair-thin jet of medication is generated for the injection.
Automatic injection systems play an increasingly important role in the treatment of chronic illnesses. Patients can administer medication themselves at home with these devices and thus save the frequent trip to the doctor’s office. When the injection then also takes place directly through the skin without a needle, many people find it much easier to follow the prescribed treatment.
Portal Instruments has developed a needle-free automatic injection system, the injection jet of which is considerably thinner than that of the usual cannulas, and which can inject even viscous medications through the skin in less than a second. The device is also networked through the Internet so that the correct treatment can be monitored by the patient, and possibly also by the physician.
Needle-free automatic injection system from Portal Instruments
Gerresheimer, together with Portal Instruments, has now developed a drug container that fulfils the high demands of the medication and the injection procedure. Portal Instruments decided in favour of Gerresheimer as a development partner because the company possesses know-how in the development and production of syringes of COP.
“For this project, we were able to access our experience from our own product, the polymer syringe Gx RTF ClearJect, and develop a customized solution on this basis,” Manfred Baumann (Global Executive Vice President Sales & Marketing, Administration & TCC, Management Board, Gerresheimer Regensburg GmbH) explains. Most modern, highly effective medications are today manufactured with biotechnological methods.
These sometimes very expensive medications make especially high demands of their primary packaging. COP (Cyclo Olefin Polymer) is often used as a material for pre-fillable syringes and cartridges. The unbreakable, clear-as-glass material hardly interacts with the highly sensitive active agents and is therefore well-suited for the storage and administering of the medication.
Especially challenging in the project was the development of the nozzle and its fastening in the cartridge. The nozzle is a micro-injection moulding part with an inner diameter smaller than 200 µm.
The connection with the cartridge body is generated via laser welding as it is an adhesive-free solution that eliminates the possibility of chemical contamination of the medication solution. However, the laser welding of two transparent components (Clear to Clear) is especially challenging and care needs to be taken not to deform the precise nozzle by the heat generated from the laser. Mould-making, production of the syringe body, and of clinical samples took place at the Gerresheimer location in Wackersdorf.
At Pharmapack 2020 in Paris – Porte de Versailles
Gerresheimer will present its sustainable and innovative packaging and administration solutions at the Pharmapack in Paris on February 5 and 6 at booth B60/B64 in hall 7.2.
Gerresheimer is one of the world’s leading partners of the pharmaceuticals and healthcare industries. With special products of glass and plastic, the company contributes to health and well-being. Gerresheimer is represented worldwide and, with around 10,000 employees, there where its customers and markets are. With works in Europe, North and South America, and Asia, Gerresheimer generated sales of around 1.4 billion Euro.
The broad range of offerings encompasses pharmaceuticals packaging, as well as products for the simple and safe administering of medication: insulin pens, inhalers, pre-fillable syringes, injection vials, ampules, flasks, and containers for liquid and solid medications with sealing and safety systems, as well as packaging for the cosmetics industry.
About Portal Instruments
Portal Instruments develops administering systems for the creation of a commercial, networked platform for the needle-free administering of medication for the treatment of chronic illnesses. With an innovative, needle-free injector with connectivity, analysis, and digital accompaniment, Portal wants to improve patient experiences and results.
The company has entered into a pioneering partnership with the Japanese pharmaceuticals company group Takeda in order to bring this vision onto the market with a combination of medication and administering systems in the segment of inflammatory intestinal disorders.
For more information, please fill out the enquiry form attached to this page.